showed an increasing trend (but not statistically significant) in mortality in patients with ACEI/ARB, which is in contrast to the finding of this meta-analysis; this might be due to the fact that around 50% of the patients in their study used ACEI/ARB as home medication, which was discontinued during the course of hospitalization.
← all excerpts
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
1
—
—